Acceleron’s ACE-083 clinical trial is now open
[…] in a specific set of muscles may provide a clinical benefit to patients, such as FSHD. As an “investigational” agent, ACE‐083 is not approved by any regulatory agency for use […]
Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] in a specific set of muscles may provide a clinical benefit to patients, such as FSHD. As an “investigational” agent, ACE‐083 is not approved by any regulatory agency for use […]
[…] (cover story); Patient’s brother competes in American Ninja Warrior on NBC to raise awareness about FSHD (cover story); The establishment of a new registry for FSH patients and family members […]
[…] MD, PhD. Please accept our heartfelt thanks for your dedication to unlocking the mystery of FSHD and for your guidance, concern and care for patients and their families worldwide. For […]
[…] Biosciences announced this week that it had received FDA Orphan Drug Designation for its experimental FSHD treatment, called AOC 1020. This does NOT mean the drug is now available for […]
[…] reflect the chance in name from Epic Bio to Epicrispr Biotechnologies. Leading-edge CRISPR biotech chooses FSHD as its first disease target Epicrispr Biotechnologies, based in the San Francisco Bay Area, […]
Notifications